The JNK Signalsome and its Functions

JNK Signalsome 及其功能

基本信息

  • 批准号:
    7608711
  • 负责人:
  • 金额:
    $ 28.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): c-Jun N-terminal protein kinase (JNK; also known as stress-activated protein kinase, SAPK) plays a central role in proliferation, differentiation, programmed cell death and transformation. Overwhelming evidence implicates that JNK is a key regulator in many pathophysiological events including inflammation, immune responses, diabetes, obesity, heart hypertrophy, and oncogenesis. However, the molecular mechanism by which JNK activity is regulated by distinct extracellular stimuli is still incompletely understood. In this proposal, we will investigate whether JNK activation by distinct extracellular stimuli is mediated by a JNK signalsome, which is a dynamic protein complex that includes JNK-associated, stimulus-specific modulators or regulators (SMOR). Using both genetic and biochemical approaches, we recently found that JNK forms a protein complex and its activity can be regulated by stimulus-specific regulators. Furthermore, we found that two ubiquitously expressed JNK isoforms, JNK1 and JNK2, are differentially regulated by various extracellular stimuli. Thus, we hypothesize that the stimulus-specific JNK signalsome determines JNK activation by environmental stimuli and/or embryonic development cues. This proposal is novel, as it will identify the JNK signalsome } a dynamic and functional protein complex for JNK activation, and determine the molecular mechanisms by which JNK1 and JNK2 are differentially regulated at different developmental stages. This study will put forward a novel paradigm regarding the molecular mechanism underlying the regulation of the JNK mitogen-activated protein kinase subfamily by extracellular stimuli and the rationale in targeting JNK for prevention and treatment of human diseases and cancer. PUBLIC HEALTH RELEVANCE: The cell signaling network is composed of many important signaling pathways, including the stress activated protein kinase JNK pathway, which plays a central role in many pathophysiological events and has been implicated in numerous human diseases and certain types of cancer. However, it is difficult to target JNK for therapeutic purposes without affecting normal physiological functions in human. This proposal studies the molecular mechanism by which stimulus-specific modulators or regulators control JNK activation by specific extracellular stimuli, thereby providing a novel strategy to target the unique modulators or regulators of JNK, rather than JNK itself, for prevention and treatment of human diseases and cancer.
描述(由申请人提供):c-Jun N端蛋白激酶(JNK;也称为应激激活蛋白激酶,SAPK)在增殖、分化、程序性细胞死亡和转化中发挥核心作用。压倒性的证据表明,JNK 是许多病理生理事件的关键调节因子,包括炎症、免疫反应、糖尿病、肥胖、心脏肥大和肿瘤发生。然而,JNK 活性受不同细胞外刺激调节的分子机制仍不完全清楚。在本提案中,我们将研究不同细胞外刺激的 JNK 激活是否由 JNK 信号体介导,JNK 信号体是一种动态蛋白复合物,包括 JNK 相关的刺激特异性调节剂或调节剂 (SMOR)。通过遗传和生化方法,我们最近发现 JNK 形成蛋白质复合物,其活性可以通过刺激特异性调节因子进行调节。此外,我们发现两种普遍表达的 JNK 亚型 JNK1 和 JNK2 受到各种细胞外刺激的差异调节。因此,我们假设刺激特异性 JNK 信号体通过环境刺激和/或胚胎发育线索决定 JNK 激活。该提议是新颖的,因为它将鉴定 JNK 信号体(一种用于 JNK 激活的动态功能蛋白复合物),并确定 JNK1 和 JNK2 在不同发育阶段差异调节的分子机制。这项研究将提出一个新的范式,涉及细胞外刺激调节 JNK 丝裂原激活蛋白激酶亚家族的分子机制,以及靶向 JNK 预防和治疗人类疾病和癌症的基本原理。公共健康相关性:细胞信号网络由许多重要的信号通路组成,包括应激激活蛋白激酶 JNK 通路,该通路在许多病理生理事件中发挥核心作用,并与许多人类疾病和某些类型的癌症有关。然而,在不影响人体正常生理功能的情况下,很难以 JNK 为靶点进行治疗。该提案研究了刺激特异性调节剂或调节剂通过特定的细胞外刺激控制JNK激活的分子机制,从而提供了一种新的策略来针对JNK的独特调节剂或调节剂,而不是JNK本身,用于预防和治疗人类疾病和癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JING LIU其他文献

JING LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JING LIU', 18)}}的其他基金

The transcription factor Miz1-mediated mechanism of lung aging
转录因子Miz1介导的肺衰老机制
  • 批准号:
    10198018
  • 财政年份:
    2020
  • 资助金额:
    $ 28.69万
  • 项目类别:
The transcription factor Miz1-mediated mechanisms of lung aging
转录因子Miz1介导的肺衰老机制
  • 批准号:
    9764468
  • 财政年份:
    2018
  • 资助金额:
    $ 28.69万
  • 项目类别:
Regulation of Inflammation and Acute Lung Injury by the Transcription Factor Miz1
转录因子 Miz1 对炎症和急性肺损伤的调节
  • 批准号:
    8630795
  • 财政年份:
    2014
  • 资助金额:
    $ 28.69万
  • 项目类别:
Regulation of Inflammation and Acute Lung Injury by the Transcription Factor Miz1
转录因子 Miz1 对炎症和急性肺损伤的调节
  • 批准号:
    8787773
  • 财政年份:
    2014
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    8007522
  • 财政年份:
    2010
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    7841897
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    7464527
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    8037653
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    8231495
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:
The JNK Signalsome and its Functions
JNK Signalsome 及其功能
  • 批准号:
    7714765
  • 财政年份:
    2008
  • 资助金额:
    $ 28.69万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 28.69万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 28.69万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 28.69万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了